Toxicities of Targeted Therapy and Their Management in Kidney Cancer Giuseppe Di Lorenzo, Camillo Porta, Joaquim Bellmunt, Cora Sternberg, Ziya Kirkali, Michael Staehler, Steven Joniau, Francesco Montorsi, Carlo Buonerba  European Urology  Volume 59, Issue 4, Pages 526-540 (April 2011) DOI: 10.1016/j.eururo.2011.01.002 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Management and screening of hypothyroidism for sunitinib. Adapted by permission from Macmillan Publishers Ltd: [30], copyright (2008). TSH=thyroid-stimulating hormone; T4=thyroxine; FTI=free thyroxine index. European Urology 2011 59, 526-540DOI: (10.1016/j.eururo.2011.01.002) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 Management of hypertension. BP=blood pressure; AHT=anti-hypertensive therapy; ACT=anti-cancer therapy. European Urology 2011 59, 526-540DOI: (10.1016/j.eururo.2011.01.002) Copyright © 2011 European Association of Urology Terms and Conditions